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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A276The aim of this study was to elucidate further the role of miR-455 in
cartilage and OA by identifying direct targets of miR-455 in chon-
drocytes. In this study we have shown that miR-455 directly targets a
number of genes including Sirtuin 1 (Sirt1). Sirt1 is a NADþ
dependent protein deacetylase implicated in aging and age-related
diseases, including OA. Previous studies have shown that Sirt1 pro-
motes chondrocyte survival and is down-regulated in OA cartilage.
Mice deﬁcient for Sirt1 develop premature OA like changes. Here we
show that miR-455 directly targets Sirt1 and can regulate IL-1b sig-
nalling through NFkB, potentially regulating acetylation of Sirt1 tar-
get proteins such as NFkB/p65.
Methods: To identify potential targets of miR-455 we performed whole
genome mRNA and miRNA array analysis in the ATDC5 cell model of
chondrogenesis and mRNA array in primary chondrocytes following
overexpression or inhibition of miR-455. Whole genome mRNA
microarray used the Illumina Human HT-12 v4 Expression BeadChip;
miRNA microarray used the Exiqon miRCURY LNA Array. We further
analysed the data to identify regulated genes that also contain miR-455
binding sites. The 30UTR of potential targets were cloned into pmiR-GLO
and luciferase assays performed. The kB-luc reporter plasmid was used
to examine the effect of miR-455 on IL-1b-induced NFkB signalling.
Results: Whole genome array and bioinformatics analyses have iden-
tiﬁed a number of potential targets of miR-455, including Sirt1. Sirt1
mRNA is regulated across chondrogenesis inversely ot miR-455. Sirt1
mRNA levels decrease when miR-455 is overexpressed and increase
when miR-455 is inhibited. Sirt1 also contains a number of miR-455
binding sites. Luciferase assays conﬁrmed that Sirt1 is a direct target of
miR-455. A protein substrate of Sirt1 is NFkB/p65. We therefore used an
NFkB -responsive reporter to examine the effect of miR-455 on IL-1b
signalling through this pathway. Both miR-455 and a Sirtuin inhibitor,
nicotinamide, decreased IL1-b signalling. We are currently looking at
the effect of miR-455 on the acetylation of Sirt1 target proteins.
Conclusions: We have used bioinformatic analyses of mRNA/miRNA
expression datasets to identify a number of genes that are direct targets
of miR-455, including Sirt1. We have validated Sirt1 as a miR-455 target.
We have also shown that miR-455 can regulate IL1 signalling through
NFkB which is potentially due to altered acetylation of Sirt1 substrates,
including p65. This represents an important control mechanism for
Sirt1, a factor implicated in osteoarthritis.
OA: Ligament/Meniscus/Tendon/Muscle
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Purpose: Meniscal pathology is associated with osteoarthritis (OA)
progression including increased bone marrow lesions (BMLs). How-
ever, no study has accounted for the different types of meniscal
pathology and its association with BMLs or total knee arthroplasty
(TKA). The aim of this study was to explore the association of dif-
ferent types of knee meniscal pathology with BML volume, change in
BML volume over 2 years, and a proxy for TKA according to a
modiﬁed Escobar algorithm.
Methods: We selected a convenience sample of the Osteoarthritis Ini-
tiative (OAI) who had symptomatic knee OA and complete data for the
OAI Bone Ancillary Project. The right knee was selected as the index
knee unless there was a contraindication for magnetic resonance (MR)
imaging. A single experienced fellowship trained musculoskeletal
radiologist reviewed the 24-month OAI MR images for meniscal path-
ology by location (i.e., anterior, body, and posterior horn) within the
medial and lateral menisci using a modiﬁed International Society of
Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine (ISAKOS)
meniscal tear classiﬁcation system. For analyses, we reclassiﬁed the 10
original ISAKOS categories into 5 categories: normal, degenerative sig-
nal, morphological deformity, any tear (i.e., horizontal, horizontal ﬂap,vertical-longitudinal, radial, radial-longitudinal, complex tear), and
maceration. Total number of regions affected by meniscal pathology (0-
6) was calculated by counting the number of regions in medial and
lateral menisci that had pathologic ﬁndings. BML volume assessment
was performed using a semi-automated segmentation method at 24
and 48 month visits. A CART regression was performed to identify the
meaningful abnormal BML volume cut-off value (1cm3) using medial
joint space narrowing progression as outcome. We categorized the 24-
month BML volume into 3 categories: 1) no meaningful BML volume (<
1cm3), 2) >¼ 1 cm3 and below median value (2.15cm3) and 3) above
median value of meaningful BML volume. The change in BML volume
was categorized to 4 groups: 1) no meaningful BML volume (<1cm3) at
both time points, 2) lowest quartile of meaningful BML volume change
(BML volume >¼ 1.00 cm3 at both times& BML volume change <¼-0.75
cm3), 3) middle 2 quartile of the BML volume change (BML volume >¼
1.00 cm3 at both times& BML volume change>-0.75 cm3&<¼1.00 cm3),
4) highest quartile of the BML volume change (BML volume >¼ 1.00 cm3
at both times & BML volume change >1.00 cm3). We categorized the
proxy for TKA into appropriate and non-appropriate based on the
algorithm developed by Escobar et al and adapted to OAI by Riddle et al.
To replicate prior studies, we explored whether the presence or absence
of any meniscal pathology was associated with BMLs and a proxy for
TKA. Logistic regression (ordinal for Table 1 and binary for Table 2) was
performed to determine the association of baseline meniscal pathology
with BML volume, change in BML volume and a proxy for TKA. All
models were adjusted for age, sex and body mass index (BMI).
Results: 400 participants were included in the analysis with mean age of
63 (9.2) years, 53%male, BMI29.6 (4.6) kg/m2, 71%KLgrade>¼2, andwith
86% having any type of meniscal pathology. Tables below provide the
associations betweenmeniscal pathology and BML volume (Table 1), BML
volume change (Table 1) and proxy for TKA (Table 2). There was a sig-
niﬁcant association between any meniscal pathology with BML volume
(OR:3.87) and change in BML volume (OR:2.32) but not with proxy for
TKA. Having more number of regions of the menisci affected with path-
ology was associated with greater BML volume, change in BML volume,
andproxy for TKA than thosewith a normalmeniscus. Among the types of
meniscal pathology, only morphological deformity and maceration were
associated with BML volume, change in BML volume, and proxy for TKA.
Removing surgery or injury cases did not change our results.
Conclusions: Among the ﬁve categories of meniscal pathologies, dis-
ruptive pathology rather than degenerative or discrete tear was asso-
ciated with structural changes and a later clinical state that is proxy for
TKA. This suggests that pathologies that impair normal load distribution
properties of meniscus can cause damage to the knee joint.
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Purpose: Meniscal pathology increases the risk for the incidence and
progression of knee osteoarthritis but is only weakly related to knee
pain. However, the association of meniscal pathology with knee pain
has primarily been analyzed based on the presence or absence of
meniscal pathology, which does not account for the type of meniscal
pathology. We hypothesize that certain types of meniscal pathology
may relate to knee pain andmay predict change in knee pain. The aim of
this study was to explore the association of different types of knee
meniscal pathology with knee pain and change in knee pain over 2
years.
Methods: We selected a convenience sample of the Osteoarthritis
Initiative (OAI) who had complete data for the OAI Bone Ancillary
Project. The right knee was selected as the index knee unless there was
a contraindication for magnetic resonance (MR) imaging. A single
experienced fellowship trained musculoskeletal radiologist reviewed
the 24-month OAI MR images for meniscal pathology by location (i.e.,
anterior, body, and posterior horn) within the medial and lateral
menisci using a modiﬁed International Society of Arthroscopy, Knee
Surgery, and Orthopaedic Sports Medicine (ISAKOS) meniscal tear
classiﬁcation system. For analyses, we reclassiﬁed the 10 original
ISAKOS categories into 5 categories: normal, degenerative signal,
morphological deformity, any tear (i.e., horizontal, horizontal ﬂap,
vertical-longitudinal, radial, radial-longitudinal, complex tear), and
maceration. To replicate prior studies, we explored whether the
presence or absence of any meniscal pathology in a knee was asso-
ciated with pain. Total number of regions affected by meniscal path-
ology for each knee (0-6) was calculated by counting the number of
regions that had pathologic ﬁndings. Knee pain was assessed usingWestern Ontario andMcMaster Osteoarthritis Index (WOMAC) scale at
24 and 48 months. Knee pain at 24 months was categorized into 3
categories: 1) no or little pain (WOMAC pain score 0 or 1), 2) mild pain
(WOMAC pain score 2 or 3), 3) moderate-severe pain (WOMAC pain
score > 3). Longitudinally, we categorized the change in pain into 3
categories based on the presence or absence of pain and a clinically
meaningful change in pain (absolute change of 2 or relative change of
40%): 1) no pain or a meaningful decrease in pain (reference category),
2) pain but no change over time, and 3) meaningful increase in pain.
Ordinal logistic regression was performed to determine the associa-
tion of baseline meniscal pathology with knee pain and change in knee
pain over 2 years. All models were adjusted for age, sex, and bodymass
index (BMI).
Results: 465 participants were included in the analysis with mean age
of 63.2 (9.1) years, 53% male, mean BMI 29.5 (4.5) kg/m2, 71% KL grade
>¼2, and 86% with any type of meniscal pathology. Tables below show
the associations of meniscal pathology with knee pain (Table 1) and
change in knee pain (Table 2). There was no association between
presence of any meniscal pathology with knee pain or change in knee
pain. Having all six meniscal regions affected with any pathology was
associated with greater pain (OR:2.65) compared to those with normal
menisci. However, having more affected meniscal regions was not
related to an increase in pain. This pattern persisted when the number
of regions affected by maceration was analyzed cross-sectionally and
longitudinally. When we assessed the types of meniscal pathology,
cross-sectionally, the only signiﬁcant associationwas betweenmeniscal
maceration and greater knee pain (OR:2.89). Longitudinally, there was a
signiﬁcant association between morphological deformity (OR:1.46) and
increase in knee pain over 2 years. Removing surgery or injury cases did
not change our results.
Conclusions: These results suggest that meniscal maceration is
associated with higher knee pain that may not change over time.
However, we hypothesize that morphological deformity may lead to
maceration over time, which may explain why morphologic deformity
is associated with an increased pain over time. Further prospective
studies are warranted to determine if discrete tear incidence is related
to acute knee pain and if a subset of knees can then function without
pain.
